Literature DB >> 4392541

The effect of catecholamine infusions on myocardial blood flow, metabolic heat production and on general haemodynamics, before and after alprenolol (H56-28), in anaesthetized cats.

J R Parratt, R M Wadsworth.   

Abstract

1. In cats anaesthetized with pentobarbitone sodium, infusions of adrenaline, noradrenaline (0.5 mug/kg per min) and isoprenaline (0.25 mug/kg per min) increased myocardial blood flow, myocardial heat production, left ventricular systolic and end-diastolic pressures, left ventricular +ve and -ve dp/dt max, and calculated cardiac output, effort and oxygen consumption. These effects (apart from the effect of noradrenaline on left ventricular systolic pressure) were markedly reduced by previous administration of alprenolol (0.5 or 1.0 mg/kg).2. Infusions of adrenaline and noradrenaline increased arterial diastolic blood pressure and isoprenaline reduced it. After alprenolol the effects of adrenaline and noradrenaline were potentiated and that of isoprenaline abolished; in some experiments isoprenaline increased arterial diastolic pressure after alprenolol. Alprenolol did not influence the increases in arterial systolic pressure which followed the administration of adrenaline and noradrenaline.3. Isoprenaline-induced tachycardia was markedly reduced and adrenaline tachycardia was converted to bradycardia after alprenolol. The bradycardia which occurred during noradrenaline infusions was unaffected.4. After blockade by alprenolol, recovery of the effects of isoprenaline on left ventricular dp/dt and on heart rate occurred more quickly than recovery of the effects on arterial diastolic pressure. This suggests that alprenolol has a greater affinity for beta(2)- than for beta(1)-adrenoceptors.5. Intravenous administration of acetylcholine decreased arterial blood pressure, left ventricular pressure and +ve and -ve dp/dt max. During recovery from these effects there was a marked increase in +ve dp/dt max. which was absent after the administration of alprenolol (0.5 mg/kg). Because this dose of alprenolol is thus able to block the effects of reflex sympathetic cardiac nerve stimulation but does not completely antagonize the effects of exogenous adrenaline on dp/dt, it is suggested that alprenolol may have some adrenergic neurone blocking activity.6. Increases in liver and myocardial blood flow and heat production produced by noradrenaline, adrenaline and isoprenaline were reduced after alprenolol.7. Isoprenaline reduced air-way resistance and this effect was abolished by alprenolol; increases in air-way resistance produced by adrenaline and nor-adrenaline were augmented. All three amines inhibited intestinal smooth muscle contractions in vivo. Only the effect of isoprenaline was reduced by alprenolol.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4392541      PMCID: PMC1702579          DOI: 10.1111/j.1476-5381.1970.tb10597.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Determinants of coronary flow and myocardial oxygen consumption.

Authors:  H FEINBERG; L N KATZ; E BOYD
Journal:  Am J Physiol       Date:  1962-01

2.  Myocardial blood flow in the rabbit.

Authors:  J GRAYSON; D MENDEL
Journal:  Am J Physiol       Date:  1961-05

3.  Velocity of blood flow and stroke volume obtained from the pressure pulse.

Authors:  W B JONES; L L HEFNER; W H BANCROFT; W KLIP
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

4.  Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index.

Authors:  S J Sarnoff; E Braunwald; G H Welch; R B Case; W N Stainsby; R Macruz
Journal:  Am J Physiol       Date:  1958-01

Review 5.  Oxygen consumption of the heart. Newer concepts of its multifactoral determination.

Authors:  E H Sonnenblick; J Ross; E Braunwald
Journal:  Am J Cardiol       Date:  1968-09       Impact factor: 2.778

6.  [Comparison of the maximal rate of pressure rise and systolic peak pressure of isolated perfused guinea pig hearts following the action of noradrenaline, histamine, Ca++ and digitoxigenin].

Authors:  K Greeff; P Mellinghoff; E Schlieper
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-06

7.  The effect of adrenaline, noradrenaline, and propranolol on myocardial blood flow and metabolic heat production in monkeys and baboons.

Authors:  J R Parratt
Journal:  Cardiovasc Res       Date:  1969-07       Impact factor: 10.787

8.  Changes in cardiac heat production with agents that alter contractility.

Authors:  C L Gibbs
Journal:  Aust J Exp Biol Med Sci       Date:  1967-08

9.  Myocardial and haemodynamic effects of the beta-adrenoceptor blocking drug alprenolol (H56/28) in anaesthetized cats.

Authors:  J R Parratt; R M Wadsworth
Journal:  Br J Pharmacol       Date:  1969-10       Impact factor: 8.739

10.  Studies on the mode of action of hexobendine, a prospective anti-anginal drug.

Authors:  L McInnes; J R Parratt
Journal:  Br J Pharmacol       Date:  1969-09       Impact factor: 8.739

View more
  7 in total

1.  Myocardial and circulatory effects of E. coli endotoxin; modification of responses to catecholamines.

Authors:  J R Parratt
Journal:  Br J Pharmacol       Date:  1973-01       Impact factor: 8.739

2.  The effects of dipyridamole on the myocardial vasodilator actions of noradrenaline, isoprenaline and adenosine.

Authors:  J R Parratt; R M Wadsworth
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

3.  Myocardial and haemodynamic effects of phentolamine.

Authors:  P K Das; J R Parratt
Journal:  Br J Pharmacol       Date:  1971-03       Impact factor: 8.739

4.  The effect of "selective" beta-adrenoceptor blocking drugs on the myocardial circulation.

Authors:  J R Parratt; R M Wadsworth
Journal:  Br J Pharmacol       Date:  1970-06       Impact factor: 8.739

5.  Cardiovascular pharmacology of quazodine (MJ-1988), with particular reference to effects of myocardial blood flow and metabolic heat production.

Authors:  J R Parratt; E Winslow
Journal:  Br J Pharmacol       Date:  1971-06       Impact factor: 8.739

6.  The haemodynamic effects of prolonged oral administration of oxyfedrine, a partial agonist at beta-adrenoceptors: comparison with propranolol.

Authors:  J R Parratt
Journal:  Br J Pharmacol       Date:  1974-05       Impact factor: 8.739

7.  Physical training under the influence of beta-blockade in rats. III. Effects on muscular metabolism.

Authors:  M N Harri
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1980
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.